Gene · 2746
Papers4,000
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,000
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Physico-Chemical and Rheological Trait-Based Identification of Indian Wheat Varieties Suitable for Different End-Uses. | Foods | 2024 | 38611429 | PubTator, text mining | PubMed |
| Inhibition of GLUD1 mediated by LASP1 and SYVN1 contributes to hepatitis B virus X protein-induced hepatocarcinogenesis. | J Mol Cell Biol | 2024 | 38587834 | PubTator, text mining | PubMed |
| Mulberry leaf and konjac flour compound dietary fiber improves digestion and metabolism in elderly mice with high-fish-protein diet by regulating gut microbiota structure and intestinal tissue repair. | Food Chem X | 2024 | 38550885 | PubTator, text mining | PubMed |
| Molecular characterization and zoonotic potential of Cryptosporidium spp. and Giardia duodenalis in humans and domestic animals in Heilongjiang Province, China. | Parasit Vectors | 2024 | 38528567 | PubTator, text mining | PubMed |
| Structural insights into the octamerization of glycerol dehydrogenase. | PLoS One | 2024 | 38483875 | PubTator, text mining | PubMed |
| Seedlings of Poncirus trifoliata exhibit tissue-specific detoxification in response to NH4 + toxicity. | Plant Biol (Stuttg) | 2024 | 38466186 | PubTator, text mining | PubMed |
| GRID1/GluD1 homozygous variants linked to intellectual disability and spastic paraplegia impair mGlu1/5 receptor signaling and excitatory synapses. | Mol Psychiatry | 2024 | 38418578 | PubTator, text mining | PubMed |
| Targeting glutamine metabolism exhibits anti-tumor effects in thyroid cancer. | J Endocrinol Invest | 2024 | 38386265 | PubTator, text mining | PubMed |
| Comprehensive dissection of variation and accumulation of free amino acids in tea accessions. | Hortic Res | 2024 | 38304331 | PubTator, text mining | PubMed |
| Reaction hijacking inhibition of Plasmodium falciparum asparagine tRNA synthetase. | Nat Commun | 2024 | 38297033 | PubTator, text mining | PubMed |
| A novel diabetic foot ulcer diagnostic model: identification and analysis of genes related to glutamine metabolism and immune infiltration. | BMC Genomics | 2024 | 38287255 | PubTator, text mining | PubMed |
| The Hepatokine RBP4 Links Metabolic Diseases to Articular Inflammation. | Antioxidants (Basel) | 2024 | 38275649 | PubTator, text mining | PubMed |
| Potential underreporting of treated patients using a Clostridioides difficile testing algorithm that screens with a nucleic acid amplification test. | Infect Control Hosp Epidemiol | 2024 | 38268440 | PubTator, text mining | PubMed |
| TIM-3/Galectin-9 interaction and glutamine metabolism in AML cell lines, HL-60 and THP-1. | BMC Cancer | 2024 | 38267906 | PubTator, text mining | PubMed |
| Immunogenic cell death-related classification reveals prognosis and effectiveness of immunotherapy in breast cancer. | Sci Rep | 2024 | 38263419 | PubTator, text mining | PubMed |
| The hidden face of GluD1 at inhibitory synapses. | Cell Res | 2024 | 38263278 | PubTator, text mining | PubMed |
| Acetyltransferase P300 Regulates Glucose Metabolic Reprogramming through Catalyzing Succinylation in Lung Cancer. | Int J Mol Sci | 2024 | 38256128 | PubTator, text mining | PubMed |
| Microbiota Implications in Endocrine-Related Diseases: From Development to Novel Therapeutic Approaches. | Biomedicines | 2024 | 38255326 | PubTator, text mining | PubMed |
| How Can Proteomics Help to Elucidate the Pathophysiological Crosstalk in Muscular Dystrophy and Associated Multi-System Dysfunction? | Proteomes | 2024 | 38250815 | PubTator, text mining | PubMed |
| Bioinformatics analysis identifies GLUD1 as a prognostic indicator for clear cell renal cell carcinoma. | Eur J Med Res | 2024 | 38245763 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2746/papers?page=13